Table 5.
Pooled effect sizes based on curcumin supplementation and curcumin supplementation with other advice in treating MAFLD.
| Outcomes | MD | 95% CI | p-Value | I2 |
|---|---|---|---|---|
| ALT (U/L) | −5.3047 | −8.7520, −1.8573 | 0.0026 | 6.0 |
| AST (U/L) | −3.5597 | −5.7556, −1.3638 | 0.0015 | 17.5 |
| FBI (µU/mL) | −1.1430 | −1.5439, −0.7421 | <0.0001 | 9.3 |
| HOMA-IR | −0.2884 | −0.3950, −0.1817 | <0.0001 | 0 |
| TG (mg/dL) | −12.6001 | −22.9311, −2.2692 | 0.0168 | 0 |
| TC (mg/dL) | −15.7896 | −28.2686, −3.3106 | 0.0131 | 64.6 |
| LDL-C (mg/dL) | −14.1699 | −25.9117, −2.4281 | 0.0180 | 70.8 |
| WC (cm) | −2.6303 | −4.9350, −0.3256 | 0.0253 | 0 |